Ultra High-Throughput Drug Screen for Lipid-Regulated Ion Channels
Abstract
A dearth of truly high throughput mechanisms to screen ion channels has hampered the development of pharmacological tools and therapeutics for effectively treating diseases involving ion channels (channelopathies). Ion channels are drug targets for pain, cardiac function, and neurological disorders. We have developed a soluble assay for ion channels using a phosphatidylinositol 4,5-bisphosphate fluorescentprobe (FL-PIP2) and detergent purified two pore domain potassium (K2P) and inward rectifying potassium (Kir) channels fused with a nano luciferece luminescent protein (n-Luc). The assay works by bioluminescence energy transfer (BRET).
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2019
- Accession Number
- AD1099404
Entities
People
- Scott B. Hansen
Organizations
- Scripps Research